Accessibility Menu
 
LivaNova Plc logo

LivaNova Plc

(NASDAQ) LIVN

Current Price$61.89
Market Cap$3.38B
Since IPO (1993)+415%
5 Year-19%
1 Year+56%
1 Month-12%

LivaNova Plc Financials at a Glance

Market Cap

$3.38B

Revenue (TTM)

$1.39B

Net Income (TTM)

$242.48M

EPS (TTM)

$-4.48

P/E Ratio

-13.82

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$61.89

Volume

31,426

Open

$63.78

Previous Close

$61.89

Daily Range

$60.68 - $63.78

52-Week Range

$32.48 - $71.92

LIVN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About LivaNova Plc

Industry

Healthcare Equipment and Supplies

Employees

3,300

CEO

Vladimir A. Makatsaria, MBA

Headquarters

London, W2 6LG, GB

LIVN Financials

Key Financial Metrics (TTM)

Gross Margin

68%

Operating Margin

14%

Net Income Margin

-17%

Return on Equity

-19%

Return on Capital

11%

Return on Assets

-9%

Earnings Yield

-7.24%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.38B

Shares Outstanding

54.69M

Volume

31.43K

Short Interest

0.00%

Avg. Volume

775.52K

Financials (TTM)

Gross Profit

$939.90M

Operating Income

$199.40M

EBITDA

$129.50M

Operating Cash Flow

$254.30M

Capital Expenditure

$81.10M

Free Cash Flow

$173.20M

Cash & ST Invst.

$635.60M

Total Debt

$473.30M

LivaNova Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$360.86M

+12.1%

Gross Profit

$239.78M

+9.3%

Gross Margin

66.45%

N/A

Market Cap

$3.38B

N/A

Market Cap/Employee

$1.17M

N/A

Employees

2,900

N/A

Net Income

$30.88M

-44.8%

EBITDA

$47.48M

-44.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$162.30M

+165.5%

Accounts Receivable

$216.00M

-3.4%

Inventory

$164.70M

+11.6%

Long Term Debt

$441.80M

-25.1%

Short Term Debt

$31.50M

-63.8%

Return on Assets

-9.30%

N/A

Return on Invested Capital

11.09%

N/A

Free Cash Flow

$50.20M

-26.5%

Operating Cash Flow

$82.40M

+4.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LEGNLegend Biotech Corporation
$16.80-3.95%
PBHPrestige Consumer Healthcare Inc.
$59.22-1.92%
IDYAIDEAYA Biosciences, Inc.
$30.46-5.08%
IRONDisc Medicine, Inc.
$60.09-3.10%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About LIVN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.